source: FOIAVistA/tag/r/DRG_GROUPER-ICD--ICPT/ICD1831G.m@ 636

ICD1831G ;ALB/RBS - FY 2008 DRG UPDATE ; 11/1/07 11:36am
 ;;18.0;DRG Grouper;**31**;Oct 13, 2000;Build 7
 ;
 Q
 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS^
 ;;810^16^MED^MAJOR HEMATOL/IMMUN DIAG EXC SICKLE CELL CRISIS & COAGUL W/O CC/MCC^1.0741^3.1^
 ;;811^16^MED^RED BLOOD CELL DISORDERS W MCC^1.0006^4.0^
 ;;812^16^MED^RED BLOOD CELL DISORDERS W/O MCC^0.7780^2.8^
 ;;813^16^MED^COAGULATION DISORDERS^1.3426^3.8^
 ;;814^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W MCC^1.3226^5.3^
 ;;815^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W CC^1.0233^3.9^
 ;;816^16^MED^RETICULOENDOTHELIAL & IMMUNITY DISORDERS W/O CC/MCC^0.7990^2.7^
 ;;820^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W MCC^4.4970^13.8^
 ;;821^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W CC^2.6847^5.4^
 ;;822^17^SURG^LYMPHOMA & LEUKEMIA W MAJOR O.R. PROCEDURE W/O CC/MCC^1.5989^2.7^
 ;;823^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W MCC^3.5188^12.0^
 ;;824^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W CC^2.5164^6.6^
 ;;825^17^SURG^LYMPHOMA & NON-ACUTE LEUKEMIA W OTHER O.R. PROC W/O CC/MCC^1.6201^3.3^
 ;;826^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W MCC^3.9780^13.0^
 ;;827^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W CC^2.4230^5.7^
 ;;828^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W MAJ O.R. PROC W/O CC/MCC^1.5109^2.9^
 ;;829^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W CC/MCC^2.4894^6.9^
 ;;830^17^SURG^MYELOPROLIF DISORD OR POORLY DIFF NEOPL W OTHER O.R. PROC W/O CC/MCC^1.6396^2.5^
 ;;834^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W MCC^3.6361^8.9^
 ;;835^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W CC^2.5626^5.3^
 ;;836^17^MED^ACUTE LEUKEMIA W/O MAJOR O.R. PROCEDURE W/O CC/MCC^2.1785^3.4^
 ;;837^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX OR W HIGH DOSE CHEMO AGENT W MCC^4.7788^17.2^
 ;;838^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W CC OR HIGH DOSE CHEMO AGENT^2.9919^6.2^
 ;;839^17^MED^CHEMO W ACUTE LEUKEMIA AS SDX W/O CC/MCC^2.3980^4.9^
 ;;840^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W MCC^2.1454^6.8^
 ;;841^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W CC^1.6444^5.0^
 ;;842^17^MED^LYMPHOMA & NON-ACUTE LEUKEMIA W/O CC/MCC^1.2188^3.2^
 ;;843^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W MCC^1.6341^6.3^
 ;;844^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W CC^1.2403^4.5^
 ;;845^17^MED^OTHER MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC^0.9664^3.3^
 ;;846^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W MCC^1.6523^5.8^
 ;;847^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC^1.0296^2.7^
 ;;848^17^MED^CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC^0.9116^2.3^
 ;;849^17^MED^RADIOTHERAPY^1.2663^4.3^
 ;;853^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W MCC^5.1840^12.8^
 ;;854^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W CC^3.9291^9.1^
 ;;855^18^SURG^INFECTIOUS & PARASITIC DISEASES W O.R. PROCEDURE W/O CC/MCC^3.3662^5.6^
 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W MCC^3.9257^12.1^
 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W CC^2.4919^6.8^
 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS W O.R. PROC W/O CC/MCC^2.0996^4.7^
 ;;862^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W MCC^1.5454^6.2^
 ;;863^18^MED^POSTOPERATIVE & POST-TRAUMATIC INFECTIONS W/O MCC^1.0560^4.2^
 ;;864^18^MED^FEVER OF UNKNOWN ORIGIN^0.8240^3.2^
 ;;865^18^MED^VIRAL ILLNESS W MCC^1.2074^4.9^
 ;;866^18^MED^VIRAL ILLNESS W/O MCC^0.7527^2.8^
 ;;867^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W MCC^2.1971^7.2^
 ;;868^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W CC^1.5258^4.6^
 ;;869^18^MED^OTHER INFECTIOUS & PARASITIC DISEASES DIAGNOSES W/O CC/MCC^1.3611^3.5^
 ;;870^18^MED^SEPTICEMIA W MV 96+ HOURS^5.7579^12.6^
 ;;871^18^MED^SEPTICEMIA W/O MV 96+ HOURS W MCC^1.7484^5.6^
 ;;872^18^MED^SEPTICEMIA W/O MV 96+ HOURS W/O MCC^1.3783^4.7^
 ;;876^19^SURG^O.R. PROCEDURE W PRINCIPAL DIAGNOSES OF MENTAL ILLNESS^2.4632^6.9^
 ;;880^19^MED^ACUTE ADJUSTMENT REACTION & PSYCHOSOCIAL DYSFUNCTION^0.6085^2.4^
 ;;881^19^MED^DEPRESSIVE NEUROSES^0.5198^3.1^
 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.5685^3.1^
 ;;883^19^MED^DISORDERS OF PERSONALITY & IMPULSE CONTROL^0.8999^4.6^
 ;;884^19^MED^ORGANIC DISTURBANCES & MENTAL RETARDATION^0.8431^4.0^
 ;;885^19^MED^PSYCHOSES^0.7783^5.5^
 ;;886^19^MED^BEHAVIORAL & DEVELOPMENTAL DISORDERS^0.6983^4.0^
 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^0.8341^3.1^
 ;;894^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.3571^2.1^
 ;;895^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W REHABILITATION THERAPY^0.7557^8.2^
 ;;896^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W MCC^1.0419^4.8^
 ;;897^20^MED^ALCOHOL/DRUG ABUSE OR DEPENDENCE W/O REHABILITATION THERAPY W/O MCC^0.6145^3.3^
 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W MCC^2.8534^9.3^
 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W CC^1.8611^5.7^
 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES W/O CC/MCC^1.4966^3.5^
 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES W CC/MCC^2.5246^7.2^
 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES W/O CC/MCC^1.5926^3.5^
 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^0.9803^2.2^
 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W MCC^3.1030^8.1^
 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W CC^2.1865^5.0^
 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES W/O CC/MCC^1.4112^2.7^
 ;;913^21^MED^TRAUMATIC INJURY W MCC^1.0631^4.6^
 ;;914^21^MED^TRAUMATIC INJURY W/O MCC^0.6890^2.7^
 ;;915^21^MED^ALLERGIC REACTIONS W MCC^0.8660^3.3^
 ;;916^21^MED^ALLERGIC REACTIONS W/O MCC^0.4986^1.7^
 ;;917^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W MCC^1.1717^3.7^
 ;;918^21^MED^POISONING & TOXIC EFFECTS OF DRUGS W/O MCC^0.6886^2.1^
 ;;919^21^MED^COMPLICATIONS OF TREATMENT W MCC^1.2830^4.4^
 ;;920^21^MED^COMPLICATIONS OF TREATMENT W CC^0.9797^3.2^
 ;;921^21^MED^COMPLICATIONS OF TREATMENT W/O CC/MCC^0.7101^2.3^
 ;;922^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W MCC^1.1338^4.1^
 ;;923^21^MED^OTHER INJURY, POISONING & TOXIC EFFECT DIAG W/O MCC^0.7071^2.4^
 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W SKIN GRAFT^12.3042^23.0^
 ;;928^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W CC/MCC^4.3956^12.1^
 ;;929^22^SURG^FULL THICKNESS BURN W SKIN GRAFT OR INHAL INJ W/O CC/MCC^2.3533^5.6^
 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS W MV 96+ HRS W/O SKIN GRAFT^2.6626^2.7^
 ;;934^22^MED^FULL THICKNESS BURN W/O SKIN GRFT OR INHAL INJ^1.3745^4.7^
 ;;935^22^MED^NON-EXTENSIVE BURNS^1.1605^3.7^
 ;;939^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W MCC^2.1672^7.5^
 ;;940^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W CC^1.6823^4.4^
 ;;941^23^SURG^O.R. PROC W DIAGNOSES OF OTHER CONTACT W HEALTH SERVICES W/O CC/MCC^1.3531^2.3^
 ;;945^23^MED^REHABILITATION W CC/MCC^1.1005^8.4^
 ;;946^23^MED^REHABILITATION W/O CC/MCC^1.0143^7.0^
 ;;947^23^MED^SIGNS & SYMPTOMS W MCC^0.8767^3.8^
 ;;948^23^MED^SIGNS & SYMPTOMS W/O MCC^0.6542^2.7^
 ;;949^23^MED^AFTERCARE W CC/MCC^0.7323^2.5^
 ;;950^23^MED^AFTERCARE W/O CC/MCC^0.5948^2.4^
 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.6109^2.1^
 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^5.1028^8.5^
 ;;956^24^SURG^LIMB REATTACHMENT, HIP & FEMUR PROC FOR MULTIPLE SIGNIFICANT TRAUMA^3.4854^7.6^
 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W MCC^5.7960^10.5^
 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W CC^4.4786^7.9^
 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^3.6988^4.9^
 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W MCC^2.2985^6.3^
 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W CC^1.7015^5.0^
 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA W/O CC/MCC^1.4108^3.3^
 ;;969^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W MCC^5.1395^13.5^
 ;;970^25^SURG^HIV W EXTENSIVE O.R. PROCEDURE W/O MCC^3.6849^6.6^
 ;;974^25^MED^HIV W MAJOR RELATED CONDITION W MCC^2.1382^7.4^
 ;;975^25^MED^HIV W MAJOR RELATED CONDITION W CC^1.5918^5.3^
 ;;976^25^MED^HIV W MAJOR RELATED CONDITION W/O CC/MCC^1.3357^3.8^
 ;;977^25^MED^HIV W OR W/O OTHER RELATED CONDITION^1.0387^3.8^
 ;;981^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^4.5168^11.9^
 ;;982^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^3.5417^7.8^
 ;;983^99^SURG^EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^2.9737^3.9^
 ;;984^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^2.7217^11.7^
 ;;985^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.0865^7.4^
 ;;986^99^SURG^PROSTATIC O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.6706^3.5^
 ;;987^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W MCC^2.8500^9.9^
 ;;988^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W CC^2.0134^5.9^
 ;;989^99^SURG^NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS W/O CC/MCC^1.6310^2.9^
 ;;998^99^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^0^0^
 ;;999^99^**^UNGROUPABLE^0^0^
 ;;EXIT
 Q